Amalio Telenti - Toxicology

Author Information

A. Telenti is currently affiliated with The Scripps Research Institute, La Jolla, CA 92037. The primary focus of Telenti's research includes virology, immunology, and protein structure, with a significant emphasis on the SARS-CoV-2 virus. Telenti's work has been instrumental in understanding the mutational drivers, immune evasion, and neutralization mechanisms of coronaviruses.

Research Contributions

A. Telenti has made substantial contributions to the field of virology, particularly in the context of SARS-CoV-2. Notable research includes predicting future variants of concern, studying the evolution and biology of SARS-CoV-2 variants, and identifying mechanisms of immune evasion. Telenti's work also encompasses the development of human antibodies that neutralize betacoronaviruses and enhance our understanding of protein structure reconstruction. The insights provided by Telenti's research are critical for the development of therapeutic and preventive strategies against COVID-19 and other related viruses.

Aliases

A. Telenti is also known by the following aliases: A Telenti, A. Telenti, and Amalio Telenti.

Publication and Citation Metrics

Metric	Value
Citation Count	43,586
h-index	108
Paper Count	527

Publications:

Predicting the mutational drivers of future SARS-CoV-2 variants of concern

DOI: 10.1126/scitranslmed.abk3445

Year: 2022

The Evolution and Biology of SARS-CoV-2 Variants.

DOI: 10.1101/cshperspect.a041390

Year: 2022

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

DOI: 10.1126/science.abi7994

Year: 2021

Broad betacoronavirus neutralization by a stem helix–specific human antibody

DOI: 10.1126/science.abj3321

Year: 2021

MP‐NeRF: A massively parallel method for accelerating protein structure reconstruction from internal coordinates

DOI: 10.1002/jcc.26768

Year: 2021

A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery

DOI: 10.1101/2021.05.09.442808

Year: 2021

Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.

DOI: 10.1038/s41586-021-03925-1

Year: 2021

Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody

DOI: 10.1101/2021.04.07.438818

Year: 2021

MP-NeRF: A Massively Parallel Method for Accelerating Protein Structure Reconstruction from Internal Coordinates

DOI: 10.1101/2021.06.08.446214

Year: 2021

After the pandemic: perspectives on the future trajectory of COVID-19.

DOI: 10.1038/s41586-021-03792-w

Year: 2021